<DOC>
	<DOC>NCT02621827</DOC>
	<brief_summary>This study measures the plasma half-life of 25-hydroxyvitamin D3 (25(OH)D3) in non-pregnant-non-lactating women, pregnant women at 30 wk gestational age and at 3 months post-partum in women who are exclusively breast-feeding.</brief_summary>
	<brief_title>Vitamin D Half-life in Pregnancy and Lactation</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcifediol</mesh_term>
	<criteria>All participants: Currently resident in West Kiang and planning to stay for the next 5 months Aged between 18 and 45 y Pregnancy: &gt; 20 wk &lt; 30 wk pregnant (gestational age assessment by ultrasound) Singleton fetus Lactation: Breast feeding All participants: Severe anaemia (haemoglobin &lt; 7 g/dL) (as per ENID protocol) Known sickle cell anaemia Known to be asthmatic or allergic to peanuts (already excluded from ENID) Known history of liver, kidney, gut or malabsorption problems Other chronic condition On prescription medication Taking vitamin D supplements (&gt; 200 IU/d) Broken bone in last 3 y Recent infection or illness (2 weeks prior to the start of a study period) Reported onset of menopause (already excluded from ENID) Malaria parasitemia (prior to study period) Unable to consent Pregnant: Pregnancyrelated complications or on discretion of midwife Known HIV positive Lactation: Health problem of mother or infant that may affect feeding practices</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>Africa</keyword>
</DOC>